{"name":"Community Research Initiative of New England","slug":"community-research-initiative-of-new-england","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"DRV/r","genericName":"DRV/r","slug":"drv-r","indication":"HIV-1 infection in treatment-experienced patients","status":"marketed"},{"name":"Darunavir (DRV/r)","genericName":"Darunavir (DRV/r)","slug":"darunavir-drv-r","indication":"HIV-1 infection in treatment-experienced patients","status":"marketed"},{"name":"atazanavir/raltegravir","genericName":"atazanavir/raltegravir","slug":"atazanavir-raltegravir","indication":"HIV-1 infection in treatment-experienced or treatment-naive adults","status":"marketed"},{"name":"atazanavir/tenofovir/emtricitabine","genericName":"atazanavir/tenofovir/emtricitabine","slug":"atazanavir-tenofovir-emtricitabine","indication":"HIV-1 infection in treatment-naïve and treatment-experienced adults","status":"marketed"},{"name":"continue on current dual boosted PI","genericName":"continue on current dual boosted PI","slug":"continue-on-current-dual-boosted-pi","indication":"HIV-1 infection (as part of combination antiretroviral therapy)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Increased dose of Kaletra","genericName":"Increased dose of Kaletra","slug":"increased-dose-of-kaletra","indication":"Other","status":"marketed"},{"name":"Intermitent Dosing","genericName":"Intermitent Dosing","slug":"intermitent-dosing","indication":"Other","status":"marketed"},{"name":"Raltegravir plus Truvada","genericName":"Raltegravir plus Truvada","slug":"raltegravir-plus-truvada","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Increased dose of Kaletra","genericName":"Increased dose of Kaletra","slug":"increased-dose-of-kaletra","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intermitent Dosing","genericName":"Intermitent Dosing","slug":"intermitent-dosing","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DRV/r","genericName":"DRV/r","slug":"drv-r","phase":"marketed","mechanism":"DRV/r is a combination of darunavir (a protease inhibitor) boosted with ritonavir (a pharmacokinetic enhancer) that blocks HIV protease to prevent viral replication.","indications":["HIV-1 infection in treatment-experienced patients","HIV-1 infection in treatment-naive patients"],"catalyst":""},{"name":"Darunavir (DRV/r)","genericName":"Darunavir (DRV/r)","slug":"darunavir-drv-r","phase":"marketed","mechanism":"Darunavir is a protease inhibitor that blocks HIV protease, preventing the cleavage of viral polyproteins and maturation of infectious HIV particles.","indications":["HIV-1 infection in treatment-experienced patients","HIV-1 infection in treatment-naïve patients (in combination antiretroviral therapy)"],"catalyst":""},{"name":"Raltegravir plus Truvada","genericName":"Raltegravir plus Truvada","slug":"raltegravir-plus-truvada","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"atazanavir/raltegravir","genericName":"atazanavir/raltegravir","slug":"atazanavir-raltegravir","phase":"marketed","mechanism":"This combination blocks HIV protease and integrase enzymes to prevent viral replication and reduce viral load in HIV-infected patients.","indications":["HIV-1 infection in treatment-experienced or treatment-naive adults"],"catalyst":""},{"name":"atazanavir/tenofovir/emtricitabine","genericName":"atazanavir/tenofovir/emtricitabine","slug":"atazanavir-tenofovir-emtricitabine","phase":"marketed","mechanism":"This is a fixed-dose combination of three antiretroviral drugs that work together to inhibit HIV replication through different mechanisms: atazanavir blocks protease, while tenofovir and emtricitabine inhibit reverse transcriptase.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced adults","HIV-1 infection in combination antiretroviral therapy"],"catalyst":""},{"name":"continue on current dual boosted PI","genericName":"continue on current dual boosted PI","slug":"continue-on-current-dual-boosted-pi","phase":"marketed","mechanism":"Dual-boosted protease inhibitors block HIV protease to prevent viral replication and reduce viral load in HIV-infected patients.","indications":["HIV-1 infection (as part of combination antiretroviral therapy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPeEVQV1YtaFVRajQtQ0VrV0hzOFc0NGNlbnJxbmdSNVhNTzJhM1lhUXNyVTZNbTJzOE1naENhaHpnSnNIQi1LdXRSRjluenBIcGM3N0w0a0RzRkJDdkVZdnQ2TVhNdmMtUjEtU2lFYlZ3UHZtRmZGSTZ1Qm1YT0xCOHF1cHRRYm1pNVVaZnktaXJvd2JDVWVFRXpqMlB0Z00xZEFSckhHXzZlLVlIamkwUFg1TFpFa3hfZl9XenBFQQ?oc=5","date":"2026-03-05","type":"deal","source":"The Bay State Banner","summary":"Greater Boston Food Bank, Takeda partnership takes aim at improving community health - The Bay State Banner","headline":"Greater Boston Food Bank, Takeda partnership takes aim at improving community health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPQUEwaE1ocmZSemcydEFUdG9fN2VNOWNIRGpobFQtSVBFVGJmczFSR2JlSk11STREUzU4OHZDSlBxSENET1g5QTFjWXZnN2xjSVZzQzFxem5UM1J1WkJKZTRMWGdHOTJ6Z25JODJwWE9tRFItMzJtRnppYjMzSkdBb095NDZCakM0TU1DUm5TRQ?oc=5","date":"2026-03-03","type":"pipeline","source":"New Jersey Business & Industry Association","summary":"HINJ Life Sciences Summit to Focus on NJ’s Pharma and Medtech Future - New Jersey Business & Industry Association","headline":"HINJ Life Sciences Summit to Focus on NJ’s Pharma and Medtech Future - New Jersey Business & Industry Association","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQeVVZU041dnVZMW52VnlfdWlzUUExOUZKeFppS0c4YkRHbTY1YW1CZi1aUExic1FEVER6Q2V4NHNFU3BXcTJodjY5bEtTckVpa0tUNkpFSVhLTldjZkZ1ZDIycmFfYWExZXQ1dlp2b2xVRFY3T3FidjlCM3VVQ1pHMDM5XzN1ajZDd1VzR3FKeDJsOE4yOTJhWlJ6X0dtVmd3NGF6cUExNE1ta0tzaHp0Z2ZJMWFabUtGYzIwR2Z4dw?oc=5","date":"2026-01-26","type":"pipeline","source":"pharmaceutical-journal.com","summary":"Community pharmacy in focus: research insights on improving patient care - pharmaceutical-journal.com","headline":"Community pharmacy in focus: research insights on improving patient care - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQbzZ1MzlvRkxuX0l6cWd4OURMRHpyYVFORjRGNEdkZmlpZW9vNlBYUnJFQ3c1XzRnVTJOLUZvZ0xoMUVoVEZySXk0d20zaFc4R1NIeC1MaHpVYkJEOXJ5M3VyWk5Mbm4tOXJzU25ieWEtQTRDZnlXWlF6QmVYNVltQWtIdjFRUnR2bnh3R2FuZ1FySjhpUVFfZG5SSnplNHlpZm41bnAtMFhOa2FDUTZ4NDhnSGlDdVloQXIxRFNfNk5nTjhxSGc?oc=5","date":"2026-01-23","type":"pipeline","source":"pharmaceutical-journal.com","summary":"From dispensing to research: a new service opportunity for community pharmacy - pharmaceutical-journal.com","headline":"From dispensing to research: a new service opportunity for community pharmacy - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxONlNleDFPUXBxMkJmcnJJUzVUeHRiSURBc182eGhUMm9DeDRGNXpJZ3hWbGhSekZwbHQ4VVNXOXMwc2UzdmN4ZEZJU25VZlBVaGlaTFBsZUdjd3BoQmJjTi1iY09NMVRnTGszd0pWLUtsZ0ZRa2RJYnFacUFSRHpIU08yVEpVdVltV2x3LTV6UXRVT0JicUV2QW5YR0hCUTZxQ0xzZUducVl0eXUzSWI3d213cVVVY1JZYy1QbFZ4WTd1ZkJXTmEw?oc=5","date":"2025-11-19","type":"trial","source":"The Brown Daily Herald","summary":"Brown researchers study rise of substance use in New England with new $12M grant - The Brown Daily Herald","headline":"Brown researchers study rise of substance use in New England with new $12M grant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOZjJhY1M4TU9hSnQ1TXlRWTlmMEZ0ZlNubUNweWtkS2pjY3k5U1lnQzl6WkNkeFBWcExkdTJxUlN4QWI4WTl0R01tcW1zcmFDWHgxTjZZdHphd0puN2NybUtKUXJqcTZPMEZmMHItVzQxWTNJZ0dfS2tUNHpINDFmRzVGRnFHZ1ZVY2xNTWRhWmdBV2VySGxkc2t1Y0Y4aHkwSGRpTU5lT3JXYTZqZUxzUjZJb05HVDRtVFE?oc=5","date":"2025-10-22","type":"pipeline","source":"University of Houston","summary":"College News | College of Pharmacy - University of Houston","headline":"College News | College of Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9xbEc5azJ2dHJVcFJJQkJuT0ZIWHpPRENrV3BhN1oxb0RGWlZoNUEyMjhHX09MVkpkTjZwX1kzZVZfRWg5aTBmdzRYR2RnVXRrRE5ySXo5MWZ0N0JTZ1RlWW4wekNQNnFPSGJ0aE9sNFZwRVRCczFSM3ltUy0?oc=5","date":"2025-09-08","type":"pipeline","source":"nia.nih.gov","summary":"2025 NIH Alzheimer’s Disease and Related Dementias Research Progress Report: Advances and Achievements - nia.nih.gov","headline":"2025 NIH Alzheimer’s Disease and Related Dementias Research Progress Report: Advances and Achievements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZUZPWmFDX0Z5TVBQNGdzcFFTZ192UVJ5d0ZrcVZZSTJ1N1lfakJjWWtZNUJWMGs5NEc5ZUNqcWhmbkl0ZGxZc2pJVzFwbU1iX0pVeG04eXZScFQ2cHJUNVBJQ0o5QjRzYVdhQV9LdG1CbzZpbzhiWWo2dHk0bUc2UDNMODNERlhpeGhB?oc=5","date":"2024-12-12","type":"pipeline","source":"The Lancet","summary":"Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis - The Lancet","headline":"Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England du","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9Cb0FkNUNiMWJoOWx3cmR1cFlUTVdLUGxiMFh0N0N0SHliNUJLeHp0ZU9IMWJUN2V3QXczcGw4OGpxQlJFSEd2OGI3a3pBck0wSUtrVXZPRFhGRTBKSDEwM1E0RTdXbDZBWDNB?oc=5","date":"2024-09-10","type":"pipeline","source":"Roche","summary":"pRED Center Basel, the future of pharmaceutical innovation - Roche","headline":"pRED Center Basel, the future of pharmaceutical innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ZQlNQVUN6Mm84NldOLWJwUjZ1Ym9pRW1CejBabWQzenpLTWwxcW80NXV0d0ptc0VjUVoyVGpET2lncDlvNnZTV2VZXzNKWlRUTVhIOExfSVhaQXJrMFFR?oc=5","date":"2024-08-20","type":"pipeline","source":"Nature","summary":"Whistleblowing in science: this physician faced ostracization after standing up to pharma - Nature","headline":"Whistleblowing in science: this physician faced ostracization after standing up to pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQeXU2UVV5ZWN0YUxMeEoxTHZwSW9OYkdQS0JKR1NzUEhmSHBuN2hTUFV2dm5ucE9rSFlFVmlDa1dTbk80V3pDMEZwSWQ3Q0pGbVBrNDE2R2tEQVY2QWNjRUFNSzZiemJaeFg4SUIwSzMxMUVkb2R3cktOUTdMR0d6MmFCVndRYk1mRUhNaFMxZVBva09MbUNHUUYxbFp2bmFDQzQzWG9qUVlqYzBadmVra2JDLTF0TGZkNHR5TW9n?oc=5","date":"2023-11-13","type":"pipeline","source":"Deloitte","summary":"Broadening research participation through community engagement - Deloitte","headline":"Broadening research participation through community engagement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE84ZWpmX29kMEZ0VkNzYmt0MnpxbkpYdFZ5M1Q1c2djY3Z5MHZyN0ZGX1NRNkdPYnJfVm9VcjYwb29lc1RiWFNiTUlUcDVWN3lsTWtjTDlBa2RYcGRGT3NwNA?oc=5","date":"2019-08-14","type":"pipeline","source":"NEJM","summary":"The “All of Us” Research Program - NEJM","headline":"The “All of Us” Research Program","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"marketed":8},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}